Sodium Hydroxide → HCID 69458777、化合物
反応式
[Cl:1][C:2]1[CH:3]=[C:4]([C@H:8]2[O:12]C(=O)[N:10]([C@H:14]([CH3:30])[CH2:15][C:16]3[C:24]4[C:19](=[C:20]([NH:25][C:26](=[O:29])[CH2:27][CH3:28])[CH:21]=[CH:22][CH:23]=4)[NH:18][CH:17]=3)[CH2:9]2)[CH:5]=[CH:6][CH:7]=1.[OH-].[Na+]>C(O)C>[Cl:1][C:2]1[CH:3]=[C:4]([C@@H:8]([OH:12])[CH2:9][NH:10][C@H:14]([CH3:30])[CH2:15][C:16]2[C:24]3[C:19](=[C:20]([NH:25][C:26](=[O:29])[CH2:27][CH3:28])[CH:21]=[CH:22][CH:23]=3)[NH:18][CH:17]=2)[CH:5]=[CH:6][CH:7]=1参加物
実験手順
To a solution of N-(3-((2R)-2-((5R)-5-(3-chlorophenyl)-2-oxo-1,3-oxazolidin-3-yl)propyl)-1H-indol-7-yl)propanamide (28.4 mg, 0.0666 mmol) in ethanol (1 mL) is added a 5N aqueous sodium hydroxide solution (0.2 mL), and the mixture is stirred at room temperature for 15 hours, and further stirred at 60° C. for 11 hours. The ethanol is evaporated, and the resulting residue is separated into a saturated aqueous sodium hydrogen carbonate solution-and chloroform. The organic layer is washed with a saturated brine, and dried over anhydrous sodium sulfate. The solvent is evaporated, and the obtained crude product is purified by preparative HPLC (water-aceto-nitrile-trifluoroacetic acid), and preparative thin layer chromatography (1st; a saturated ammonia solution in chloroform-methanol=10:1, 2nd; chloroform:methanol=10: 1) to give the title compound (3.3 mg, 12.5%).
後処理
- stirringfurther stirred at 60° C. for 11 hours
- customThe ethanol is evaporated
- customthe resulting residue is separated into a saturated aqueous sodium hydrogen carbonate solution-and chloroform
- washThe organic layer is washed with a saturated brine
- dry with materialdried over anhydrous sodium sulfate
- customThe solvent is evaporated
- customthe obtained crude product
- customis purified by preparative HPLC (water-aceto-nitrile-trifluoroacetic acid), and preparative thin layer chromatography (1st
出典と根拠
- ORDレコード
- ord-e9a3ba04c76e490197eb95fcf7b596ce
- 出典データセット
- uspto-grants-2007_05
- 特許番号
- US07217724B2
反応ノート
読み込み中…